FDA Approves Cimzia To Treat Crohn’s Disease
May 15th 2008Drug InformationCrohn
A new drug has been approved to help sufferers of Crohn’s disease, the U.S. Food and Drug Administration announced today. Cimzia (certolizumab pegol) received approval for adults with moderate to severe Crohn’s disease who have not responded to conventional therapies. This product was approved with a Medication Guide.Crohn’s disease is a chronic, inflammatory bowel disease that affects more than 1 million men and women worldwide. It has no cure and its cause is unknown.
More: continued here
No Comments »
Leave a Reply
You must be logged in to post a comment.
